Sale!

CEL Gene Maturity-onset Diabetes of the Young Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CEL Gene Maturity-onset Diabetes of the Young Type 8 (MODY8) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CEL gene, which are associated with MODY8. This form of diabetes typically manifests at a young age and can be distinguished from the more common types 1 and 2 diabetes by its unique genetic background and inheritance patterns. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect specific genetic variations that lead to the development of MODY8, enabling precise diagnosis and allowing for personalized treatment plans. By identifying the condition early, affected individuals can receive targeted interventions to manage their blood sugar levels effectively, potentially improving their quality of life and preventing complications associated with diabetes.

Description

CEL Gene Maturity-onset diabetes of the young type 8 Genetic Test

Test Name: CEL Gene Maturity-onset diabetes of the young type 8 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CEL Gene Maturity-onset diabetes of the young type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young type 8.

Test Details: CEL Gene Maturity-onset diabetes of the young type 8 NGS Genetic Test is a genetic test that analyzes the CEL gene for mutations associated with maturity-onset diabetes of the young type 8 (MODY 8). MODY 8 is a rare form of diabetes characterized by high blood sugar levels that typically begin in adolescence or early adulthood. The CEL gene provides instructions for producing the carboxyl ester lipase enzyme, which is involved in the breakdown of dietary fats in the pancreas. Mutations in the CEL gene can disrupt the normal function of the enzyme, leading to impaired insulin secretion and the development of MODY 8. The NGS (Next-Generation Sequencing) technique used in this genetic test allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of genetic variants associated with MODY 8. This test can help in the diagnosis and management of individuals with suspected MODY 8, as well as in identifying at-risk family members who may benefit from early intervention and monitoring. It is important to note that this genetic test is typically ordered by healthcare professionals and should be interpreted in conjunction with clinical symptoms, family history, and other relevant information. Genetic counseling is often recommended before and after undergoing genetic testing to discuss the implications of the results and provide guidance on potential treatment and management options.

Test Name	CEL Gene Maturity-onset diabetes of the young type 8 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CEL Gene Maturity-onset diabetes of the young type 8 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young type 8
Test Details	CEL Gene Maturity-onset diabetes of the young type 8 NGS Genetic Test is a genetic test that analyzes the CEL gene for mutations associated with maturity-onset diabetes of the young type 8 (MODY 8). MODY 8 is a rare form of diabetes characterized by high blood sugar levels that typically begin in adolescence or early adulthood. The CEL gene provides instructions for producing the carboxyl ester lipase enzyme, which is involved in the breakdown of dietary fats in the pancreas. Mutations in the CEL gene can disrupt the normal function of the enzyme, leading to impaired insulin secretion and the development of MODY 8. The NGS (Next-Generation Sequencing) technique used in this genetic test allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of genetic variants associated with MODY 8. This test can help in the diagnosis and management of individuals with suspected MODY 8, as well as in identifying at-risk family members who may benefit from early intervention and monitoring. It is important to note that this genetic test is typically ordered by healthcare professionals and should be interpreted in conjunction with clinical symptoms, family history, and other relevant information. Genetic counseling is often recommended before and after undergoing genetic testing to discuss the implications of the results and provide guidance on potential treatment and management options.